Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Breast Cancer Research

Volumn 16, Issue , 2014, Pages

  Kuchenbaecker, Karoline B ^a   Neuhausen, Susan L ^b   Robson, Mark ^c   Barrowdale, Daniel ^a   McGuffog, Lesley ^a   Mulligan, Anna Marie ^d,e   Andrulis, Irene L ^f,g   Spurdle, Amanda B ^h   Schmidt, Marjanka K ⁱ   Schmutzler, Rita K ^j,k   Engel, Christoph ^l   Wappenschmidt, Barbara ^j,k   Nevanlinna, Heli ^m   Thomassen, Mads ⁿ   Southey, Melissa ^o   Radice, Paolo ^p   Ramus, Susan J ^q   Domchek, Susan M ^r   Nathanson, Katherine L ^r   Lee, Andrew ^a   Healey, Sue ^h   Nussbaum, Robert L ^s   Rebbeck, Timothy R ^r   Arun, Banu K ^t   James, Paul ^o,u   Karlan, Beth Y ^v   Lester, Jenny ^v   Cass, Ilana ^v   Terry, Mary Beth ^x   Daly, Mary B ^y   Goldgar, David E ^z   Buys, Saundra S ^z   Janavicius, Ramunas ^aa,ab   Tihomirova, Laima ^ac   Tung, Nadine ^ad   Dorfling, Cecilia M ^ae   van Rensburg, Elizabeth J ^ae   Steele, Linda ^b   v O Hansen, Thomas ^af   Ejlertsen, Bent ^af   Gerdes, Anne Marie ^af   Nielsen, Finn C ^af   Dennis, Joe ^a   Cunningham, Julie ^ag   Hart, Steven ^ag   Slager, Susan ^ag   Osorio, Ana ^ah   Benitez, Javier ^ah   Duran, Mercedes ^ai   Weitzel, Jeffrey N ^b   Tafur, Isaac ^b   Hander, Mary ^b   Peterlongo, Paolo ^aj   Manoukian, Siranoush ^p   Peissel, Bernard ^p   Roversi, Gaia ^p   Scuvera, Giulietta ^p   Bonanni, Bernardo ^ak   Mariani, Paolo ^aj   Volorio, Sara ^aj   Dolcetti, Riccardo ^al   Varesco, Liliana ^am   Papi, Laura ^an   Tibiletti, Maria Grazia ^ao   Giannini, Giuseppe ^ap   Fostira, Florentia ^aq   Konstantopoulou, Irene ^aq   Garber, Judy ^ar   Hamann, Ute ^as   Donaldson, Alan ^at   Brewer, Carole ^au   Foo, Claire ^av   Evans, D Gareth ^aw   Frost, Debra ^a   Eccles, Diana ^ax   Douglas, Fiona ^ay   Brady, Angela ^az   Cook, Jackie ^ba   Tischkowitz, Marc ^bb   Adlard, Julian ^bc   Barwell, Julian ^bd   Ong, Kai ren ^be   Walker, Lisa ^bf   Izatt, Louise ^bg   Side, Lucy E ^bh   Kennedy, M John ^bi   Rogers, Mark T ^bj   Porteous, Mary E ^bk   Morrison, Patrick J ^bl   Platte, Radka ^a   Eeles, Ros ^bm   Davidson, Rosemarie ^bn   Hodgson, Shirley ^bo   Ellis, Steve ^a   Godwin, Andrew K ^bp   Rhiem, Kerstin ^j,k   Meindl, Alfons ^bq   Ditsch, Nina ^br   Arnold, Norbert ^bs   Plendl, Hansjoerg ^bs   Niederacher, Dieter ^bt   Sutter, Christian ^bu   Steinemann, Doris ^bv   Bogdanova Markov, Nadja ^bw   Kast, Karin ^bx   Varon Mateeva, Raymonda ^by   Wang Gohrke, Shan ^bz   Gehrig, Andrea ^ca   Markiefka, Birgid ^j   Buecher, Bruno ^cb   Lefol, Cédrick ^cb   Stoppa Lyonnet, Dominique ^cb,cc,cd   Rouleau, Etienne ^cb   Prieur, Fabienne ^ce   Damiola, Francesca ^cf   Barjhoux, Laure ^cf   Faivre, Laurence ^ch,ci   Longy, Michel ^cj   Sevenet, Nicolas ^cj   Sinilnikova, Olga M ^cf,ck   Mazoyer, Sylvie ^cf   Bonadona, Valérie ^cl,cm   Caux Moncoutier, Virginie ^cb   Isaacs, Claudine ^cn   Van Maerken, Tom ^co   Claes, Kathleen ^co   Piedmonte, Marion ^cp   Andrews, Lesley ^cq   Hays, John ^cr   Rodriguez, Gustavo C ^cs   Caldes, Trinidad ^ct   de la Hoya, Miguel ^ct   Khan, Sofia ^m   Hogervorst, Frans ⁱ   Aalfs, Cora M ^cu   de Lange, J L ⁱ   Meijers Heijboer, Hanne ^cv   van der Hout, Annemarie H ^cw   Wijnen, Juul T ^cx   van Roozendaal, K E P ^cy   Mensenkamp, Arjen R ^cz   van den Ouweland, Ans ^da   van Deurzen, Carolien ^da   van der Luijt, Rob B ^db   Olah, Edith ^dc   Diez, Orland ^dd   Lazaro, Conxi ^de   Blanco, Ignacio ^de   Teulé, Alex ^de   Menendez, Mireia ^de   Jakubowska, Anna ^df   Lubinski, Jan ^df   Cybulski, Cezary ^df   Gronwald, Jacek ^df   Jaworska Bieniek, Katarzyna ^df   Durda, Katarzyna ^df   Arason, Adalgeir ^dg   Maugard, Christine ^dh   Soucy, Penny ^di   Montagna, Marco ^dj   Agata, Simona ^dj   Teixeira, Manuel R ^dk   Olswold, Curtis ^ag   Lindor, Noralane ^dl   Pankratz, Vernon S ^ag   Hallberg, Emily ^ag   Wang, Xianshu ^ag   Szabo, Csilla I ^dm   Vijai, Joseph ^c   Jacobs, Lauren ^c   Corines, Marina ^c   Lincoln, Anne ^c   Berger, Andreas ^dn   Fink Retter, Anneliese ^dn   Singer, Christian F ^dn   Rappaport, Christine ^dn   Kaulich, Daphne Gschwantler ^dn   Pfeiler, Georg ^dn   Tea, Muy Kheng ^dn   Phelan, Catherine M ^do   Mai, Phuong L ^dp   Greene, Mark H ^dp   Rennert, Gad ^dq   Imyanitov, Evgeny N ^dr   Glendon, Gord ^ds   Toland, Amanda Ewart ^dt   Bojesen, Anders ^du   Pedersen, Inge Sokilde ^dv   Jensen, Uffe Birk ^dw   Caligo, Maria A ^dx   Friedman, Eitan ^dy   Berger, Raanan ^dy   Laitman, Yael ^dy   Rantala, Johanna ^dz   Arver, Brita ^dz   Loman, Niklas ^ea   Borg, Ake ^eb   Ehrencrona, Hans ^ea,ec   Olopade, Olufunmilayo I ^ed   Simard, Jacques ^di   Easton, Douglas F ^a   Chenevix Trench, Georgia ^h   Offit, Kenneth ^c   Couch, Fergus J ^ag   Antoniou, Antonis C ^a   CIMBA, ^a   EMBRACE Study, ^a   Breast Cancer Family, ^w   GEMO Study Collaborators, ^cg   HEBON, ⁱ   KConFab Investigators, ^u   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ NETHERLANDS CANCER INSTITUTE   (Netherlands)

^j UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^k UNIVERSITY OF COLOGNE   (Germany)

^l UNIVERSITY OF LEIPZIG   (Germany)

^m UNIVERSITY OF HELSINKI   (Finland)

ⁿ ODENSE UNIVERSITY HOSPITAL   (Denmark)

^o UNIVERSITY OF MELBOURNE   (Australia)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^u PETER MACCALLUM CANCER CENTRE   (Australia)

^v CEDARS SINAI MEDICAL CENTER   (United States)

^w CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^x Och Spine at New York Presbyterian Hospitals   (United States)

^y FOX CHASE CANCER CENTER   (United States)

^z UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^aa VILNIUS UNIVERSITY   (Lithuania)

^ab State Research Institute Center for Innovative Medicine   (Lithuania)

^ac LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^ad BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^ae UNIVERSITY OF PRETORIA   (South Africa)

^af Rigshospitalet   (Denmark)

^ag MAYO CLINIC   (United States)

^ah Centro Nacional de Investigaciones Oncológicas   (Spain)

^ai UNIVERSITY OF VALLADOLID   (Spain)

^aj FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^ak EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^al CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^am UNIVERSITY OF GENOA   (Italy)

^an UNIVERSITY OF FLORENCE   (Italy)

^ao OSPEDALE DI CIRCOLO   (Italy)

^ap SAPIENZA UNIVERSITY OF ROME   (Italy)

^aq INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^ar DANA FARBER CANCER INSTITUTE   (United States)

^as GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^at ST MICHAEL'S HOSPITAL   (United Kingdom)

^au ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^av LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

^aw MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^ax UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^ay NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^az Kennedy Galton Centre   (United Kingdom)

^ba SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^bb ADDENBROOKE S HOSPITAL   (United Kingdom)

^bc Yorkshire Regional Genetics Service   (United Kingdom)

^bd UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^be BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^bf CHURCHILL HOSPITAL   (United Kingdom)

^bg GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^bh GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^bi ST JAMES S HOSPITAL   (Ireland)

^bj UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^bk WESTERN GENERAL HOSPITAL   (United Kingdom)

^bl QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^bm INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^bn ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^bo ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^bp UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^bq TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^br UNIVERSITY OF MUNICH   (Germany)

^bs UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^bt HEINRICH HEINE UNIVERSITY   (Germany)

^bu UNIVERSITY OF HEIDELBERG   (Germany)

^bv HANNOVER MEDICAL SCHOOL   (Germany)

^bw Institute of Human Genetics   (Germany)

^bx DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^by CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^bz UNIVERSITY HOSPITAL ULM   (Germany)

^ca UNIVERSITY OF WÜRZBURG   (Germany)

^cb INSTITUT CURIE   (France)

^cc INSTITUT CURIE   (France)

^cd UNIVERSITÉ PARIS DESCARTES   (France)

^ce UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^cf CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^cg GEMO Study: National Cancer Genetics Network   (France)

^ch UNIVERSITÉ DE BOURGOGNE   (France)

^ci CENTRE GEORGES FRANÇOIS LECLERC   (France)

^cj UNIVERSITÉ DE BORDEAUX   (France)

^ck HOSPICES CIVILS DE LYON   (France)

^cl UNIVERSITÉ LYON 1   (France)

^cm CENTRE LÉON BÉRARD   (France)

^cn GEORGETOWN UNIVERSITY   (United States)

^co GHENT UNIVERSITY HOSPITAL   (Belgium)

^cp ROSWELL PARK CANCER INSTITUTE   (United States)

^cq PRINCE OF WALES HOSPITAL   (Australia)

^cr OHIO STATE UNIVERSITY   (United States)

^cs NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^ct HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^cu ACADEMIC MEDICAL CENTER   (Netherlands)

^cv VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^cw UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^cx LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^cy MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^cz RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^da ERASMUS MEDICAL CENTER   (Netherlands)

^db UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^dc NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^dd VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^de CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^df POMERANIAN MEDICAL UNIVERSITY   (Poland)

^dg LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^dh HÔPITAL CIVIL   (France)

^di Université Laval   (Canada)

^dj VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^dk PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^dl MAYO CLINIC   (United States)

^dm NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^dn UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^do H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^dp NATIONAL CANCER INSTITUTE   (United States)

^dq CLALIT HEALTH SERVICES   (Israel)

^dr N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^ds MOUNT SINAI HOSPITAL   (Canada)

^dt OHIO STATE UNIVERSITY   (United States)

^du LILLEBAELT HOSPITAL   (Denmark)

^dv AALBORG UNIVERSITY HOSPITAL   (Denmark)

^dw AARHUS UNIVERSITY HOSPITAL   (Denmark)

^dx UNIVERSITY HOSPITAL OF PISA   (Italy)

^dy SHEBA MEDICAL CENTER   (Israel)

^dz KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ea LUND UNIVERSITY HOSPITAL   (Sweden)

^eb LUND UNIVERSITY   (Sweden)

^ec UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^ed NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; ERBB2 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER SUSCEPTIBILITY; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; ONCOGENE; RISK ASSESSMENT; RISK FACTOR; SH3RF2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE; TUMOR SUPPRESSOR GENE; ADULT; AGED; ALLELE; BREAST TUMOR; CANCER STAGING; CARCINOMA; FEMALE; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84928558663     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0492-9     Document Type: Article

References (26)

1. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev. 2012;21:134-47.
2. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998;90:1138-45.
3. Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res. 2005;11:5175-80.
4. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418-23.
5. Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, et al. BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol. 2007;31:121-8.
6. Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet. 2013;9:e1003173.
7. Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013;9:e1003212.
8. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45:353-61. 361e351-352.
9. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet. 2013;45:392-8. 398e391-392.
10. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013;45:371-84. 384e371-372.
11. Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet. 2012;21:5373-84.
12. Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, et al. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res. 2012;72:1795-803.
13. Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res. 2012;14:R33.
14. Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2012;21:645-57.
15. Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2011;13:R110.
16. French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, et al. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet. 2013;92:489-503.
17. Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE, et al. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res. 2007;9:104.
18. Percy C, Vanholten V, Muir G, Sobin L. New International Classification of Diseases for Oncology (Icd-O, 2nd Edition) and the Neoplasm Chapter of the 10th Revision of the International Classification of Diseases (Icd-10). Laboratory Investigation. 1990;62:A113.
19. Antoniou AC, Sinilnikova OM, Simard J, Leone M, Dumont M, Neuhausen SL, et al. RAD51 135G-- > C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studie. Am J Hum Genet. 2007;81:1186-200.
20. Barnes DR, Lee A, Investigators E, kConFab I, Easton DF, Antoniou AC. Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet Epidemiol. 2012;36:274-91.
21. Gaffey MJ, Mills SE, Frierson Jr HF, Zarbo RJ, Boyd JC, Simpson JF, et al. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. Mod Pathol. 1995;8:31-8.
22. Rigaud C, Theobald S, Noel P, Badreddine J, Barlier C, Delobelle A, et al. Medullary carcinoma of the breast: A multicenter study of its diagnostic consistency. Arch Pathol Lab Med. 1993;117:1005-8.
23. Lange K, Weeks D, Boehnke M. Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol. 1988;5:471-2.
24. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420-8.
25. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40:703-6.
26. Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015;47:164-71.